Raymond James Maintains a Buy Rating on Cardlytics Inc (CDLX)


Raymond James analyst Aaron Kessler maintained a Buy rating on Cardlytics Inc (CDLX) today and set a price target of $20. The company’s shares opened today at $16.37.

According to TipRanks.com, Kessler is a top 100 analyst with an average return of 21.6% and a 67.3% success rate. Kessler covers the Technology sector, focusing on stocks such as Alphabet Inc, TechTarget, and Facebook.

Currently, the analyst consensus on Cardlytics Inc is a Strong Buy with an average price target of $26.

See today’s analyst top recommended stocks >>

Based on Cardlytics Inc’s latest earnings release for the quarter ending June 30, the company reported a quarterly GAAP net loss of $13.05 million. In comparison, last year the company had a GAAP net loss of $2.47 million.

Based on the recent corporate insider activity of 28 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Cardlytics, Inc. engages in the development of marketing solutions through its purchase intelligence platform. It operates through the Cardlytics Direct and Other Platform Solutions segments. The Cardlytics Direct segment represents its proprietary native bank advertising channel.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts